Last reviewed · How we verify

NCT02719262

Reduced of Ambient Melamine Exposure by Melamine Workplace Intervention

Completed NA Last updated 26 September 2018
What this trial tests

NA trial testing installing ventilation in the workplace in Environmental Exposure in 24 participants. Completed in 30 December 2016.

Timeline
26 March 2016
Primary endpoint
20 November 2016
30 December 2016

Quick facts

Lead sponsorKaohsiung Medical University Chung-Ho Memorial Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment24
Start date26 March 2016
Primary completion20 November 2016
Estimated completion30 December 2016
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Who can join

Adults 20 to 65, any sex, with Environmental Exposure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators recent study has found that ambient melamine exposure can cause the increase of biomarkers of renal tubular injury in melamine manufacturing workers. Thus, in this year, the investigators will examine whether the intervention by installing ventilation in the workplace and providing personal protective equipment and education can decrease ambient melamine exposure and further decrease urinary biomarkers of renal tubular injury such as N-acetyl β-D-glucosaminidase (NAG) and β2-microglobulin (β2-MG).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Environmental Exposure

Currently open trials in the same condition.

Other Kaohsiung Medical University Chung-Ho Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02719262.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing